| Cat.No. | Name | Information |
|---|---|---|
| M9615 | DAMGO | DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents, Kd value is 3.46 nM for native μ-OPR. |
| M7014 | Naltrindole hydrochloride | Naltrindole hydrochloride is a selective non-peptide δ opioid antagonist (Ki = 0.02-0.3 nM), with much lower affinities for κ- and µ-opioid receptors (Kis = 10-66 and 6-64 nM, respectively). Naltrindole hydrochloride can cross the blood-brain barrier. |
| M1579 | Naloxone | Naloxone is an opioid inverse agonist used to counter the effects of opiate overdose. |
| M55683 | U-50488H | U-50488H is a selective κ-opioid receptor agonist. U-50488H is known to induce diuresis. |
| M54003 | DAMGO TFA | DAMGO TFA is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR. |
| M53888 | BW-180C | BW-180C ([D-Ala2, D-Leu5]-Enkephalin) is a water soluble Opioid Receptor peptide agonist. |
| M53887 | Endomorphin 1 acetate | Endomorphin 1 acetate, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. |
| M53886 | Endomorphin 1 | Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. |
| M52988 | β-Endorphin, human | β-Endorphin, human is an agonist of opioid receptor, with preferred affinity for μ-opioid receptor and δ-opioid receptor; β-Endorphin, human exhibits antinociception activity. |
| M52954 | ICI 174864 | ICI 174864 is a highly selective, potent δ-receptor antagonist. |
| M52944 | CTAP | CTAP is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. |
| M52943 | CTOP | CTOP is a potent and highly selective μ-opioid receptor antagonist. |
| M40713 | ASP8062 | ASP8062 is an orally active GABAB receptor-positive altered modulator (PAM) that can be used in studies related to opioid-related disorder (OUD). |
| M31175 | DPDPE TFA | DPDPE TFA is an opioid peptide and also a selective delta opioid receptor (DOR) agonist. |
| M30331 | [Leu5]-Enkephalin | [Leu5]-Enkephalin is a five amino acid endogenous peptide that acts as an agonist of opioid receptors. |
| M29470 | Anrikefon TFA | Anrikefon (HSK21542) TFA is a kappa opioid receptor agonist with analgesic effect. |
| M21655 | LY2795050 | LY2795050 is a short-acting selective κ(kappa)-opioid receptor (KOR) antagonist. LY2795050 has high affinity for the KOR with Ki value of 0.72 nM. LY2795050 can be used for the research of central nervous system dysfunction. |
| M21654 | BTRX-335140 | BTRX-335140 is a selective and orally active κ opioid receptor (KOR) antagonist, has antagonist activity for κOR, μOR and δOR with IC50 values of 0.8 nM, 110 nM, and 6500 nM, respectively. Navacaprant endows with favorable in vitro ADMET and in vivo pharmacokinetic profiles and medication-like duration of action in rats. |
| M21653 | GSK1521498 | GSK1521498 is a novel, potent and selective μ-opioid receptor antagonist. |
| M21325 | β-Casomorphin, human TFA | β-Casomorphin, human TFA is an opioid-like peptide that is an opioid receptor agonist. Sequence: Tyr-Pro-Phe-Val-Glu-Pro-Ile. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
